{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-057770","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.946248+00:00","generated_at":"2026-06-02T18:13:37.151420+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"iSpecimen Q1 revenue down 22% to $2.29M; net loss widens to ($0.32)/share","bullets":["Revenue $2.29M vs $2.95M YoY; specimen count fell 39% to 5,241, offset by 28% higher ASP ($437).","Net loss $2.90M ($0.32/share) vs $2.43M loss ($0.27/share) in Q1 2023; G&A up 16% to $2.10M.","Cash and securities $2.56M at Mar 31, down from $5.01M at Dec 31, 2023; ATM offering up to $1.5M.","Next Day Quotes reached 40% of all quotes; conversion rate on NQ quotes hit 91% (vs 32% in Q4 2023).","Supplier network trimmed to 140 from 243; customer count grew to 600+ (up 66 YoY)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-057770","json":"https://secwatch.observer/filing/0001104659-24-057770.json","markdown":"https://secwatch.observer/filing/0001104659-24-057770.md","text":"https://secwatch.observer/filing/0001104659-24-057770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924057770/0001104659-24-057770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924057770/tm2413655d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T18:13:37.151420+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f09ccf141e25a10bfc555b1c2ce33ba942bfeafe","claim":"iSpecimen Inc. reported for the quarter ended March 31, 2024 results: revenue approximately $2.29 million, net income approximately $2.90 million, EPS ($0.32) per share.","evidence_excerpt":"For the quarter ended March 31, 2024, revenue was approximately $2.29 million, compared to approximately $2.95 million for the quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924057770/0001104659-24-057770-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the quarter ended March 31, 2024"},{"label":"Revenue","value":"approximately $2.29 million"},{"label":"Net income","value":"approximately $2.90 million"},{"label":"EPS","value":"($0.32) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}